Shares of IXICO plc (LON:IXI – Get Free Report) traded up 16.7% on Monday. The stock traded as high as GBX 15 and last traded at GBX 14. 2,359,474 shares changed hands during mid-day trading, an increase of 1,836% from the average daily volume of 121,868 shares. The stock had previously closed at GBX 12.
IXICO Price Performance
The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The company has a 50 day moving average price of GBX 8.49 and a 200 day moving average price of GBX 8.32. The firm has a market cap of £33.28 million, a PE ratio of -7.79, a PEG ratio of -0.38 and a beta of 0.11.
IXICO Company Profile
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Read More
- Five stocks we like better than IXICO
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
